poursina hakim digestive diseases research center

Articles in 2018

18 تیر 1403 50 Views No Comments

Establishment and development of the first biobank of inflammatory bowel disease, suspected to primary immunodeficiency diseases in Iran

Assessment of anemia in patients with various types of inflammatory bowel disease under medical therapy

Combination of diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis

Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer

Transcultural Adaptation and Validation of Persian Version of Celiac Disease Questionnaire (CDQ); A Specific Questionnaire to Measure Quality of Life of Iranian Patients

Promising effect of rapamycin on multiple sclerosis

Related Posts
Extracellular vesicles: unlocking therapeutic potential in regenerative medicine

Extracellular vesicles: unlocking therapeutic potential in regenerative medicine

 18 آذر 1403
Exercise and Magnesium Sulfate Improve Infertility Caused by Lithium Carbonate in Male Rats

Do Exercise and Magnesium Sulfate Improve Infertility Caused by Lithium Carbonate in Male Rats?

 11 آذر 1403

Metabolic Disorders 2024

 4 آذر 1403
psychological Adaptation in the Patients with Irritable Bowel Syndrome

Model of Predicting Psychosocial Adaptation to Disease According to Perceived Stress and Sense of Coherence with the Mediation Role of SelfCompassion in the Patients with Irritable Bowel Syndrome

 3 آذر 1403

FGID Articles 2024

 3 آذر 1403
pan-cancer

Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan‑cancer analysis

 3 آذر 1403
The Prevalence of PD‑L1 Expression in Triple‑Negative Breast Cancer Patients and Its Correlation with Survival Rates and Other Prognostic Factors

The Prevalence of PD‑L1 Expression in Triple‑Negative Breast Cancer Patients and Its Correlation with Survival Rates and Other Prognostic Factors: A Survival Analysis

 26 آبان 1403
capacity of differentiated PD‑L1 CAR‑modified UCB‑CD34+ cells and PD‑L1 CAR‑modified UCB‑CD34+‑derived NK cells in killing target cells

Strong capacity of differentiated PD‑L1 CAR‑modified UCB‑CD34+ cells and PD‑L1 CAR‑modified UCB‑CD34+‑derived NK cells in killing target cells and restoration of the anti‑tumor function of PD‑1‑high exhausted T Cells

 26 آبان 1403
banner

Contact us

Contact Us

Email: pddrc.com@gmail.com

Phone: 09024265006

Quick access

Articles

Useful links

Poursina Hakim Holding Co

Masstec Medical Co

All site rights belong to Poursina Hakim Holding Co.

Available, you can order now!
Unavailable!
More product details